Literature DB >> 22440536

A distinctive autosomal recessive syndrome of severe disproportionate short stature with short long bones, brachydactyly, and hypotrichosis in two consanguineous Arab families.

Stavit A Shalev1, Ronen Spiegel, Zvi U Borochowitz.   

Abstract

Disproportionate short stature is a heterogeneous group of hereditary disorders, which are classified according to their mode of inheritance, their clinical skeletal and non-skeletal manifestations, and their radiological characteristics. Herein, we inform on eight individuals with severe disproportionate short stature from two unrelated consanguineous families of Arab-Muslim ancestry. The adult height of the affected individuals is between 112 cm and 127 cm, and is due to pre- and post-natal growth retardation, which probably manifests as early as the second trimester of pregnancy. At a young age, the phenotype is characterized by a short stature, a relatively large head, and a long triangular face, and this phenotype later evolves to one with in which the head is relatively small, the mandible is large and pointy. The affected individuals have normal cognitive abilities and lack any neurological deficits. Other typical features include a prominent nose, a voice with an unusual high-pitched sound, relatively small ears, clinodactyly, brachydactyly, small hands, hypoplastic fingernails, a waddling gait, and sparse hair post-pubertally. Typical skeletal changes include short long bones, especially the femurs and humeri, with mild metaphyseal changes and very short femoral necks. After due consideration of the other hereditary causes of disproportionate short stature and close examination of the pedigrees of the two families, we concluded that these eight individuals have the same hitherto unreported form of severe disproportionate short stature that is inherited in the autosomal recessive mode.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22440536     DOI: 10.1016/j.ejmg.2012.02.011

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  6 in total

1.  Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome is caused by a POC1A mutation.

Authors:  Ofer Sarig; Sagi Nahum; Debora Rapaport; Akemi Ishida-Yamamoto; Dana Fuchs-Telem; Li Qiaoli; Ksenya Cohen-Katsenelson; Ronen Spiegel; Janna Nousbeck; Shirli Israeli; Zvi-Uri Borochowitz; Gilly Padalon-Brauch; Jouni Uitto; Mia Horowitz; Stavit Shalev; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2012-07-26       Impact factor: 11.025

Review 2.  SOFT syndrome caused by compound heterozygous mutations of POC1A and its skeletal manifestation.

Authors:  Jung Min Ko; Soyoon Jung; Jieun Seo; Choong Ho Shin; Hae Il Cheong; Murim Choi; Ok-Hwa Kim; Tae-Joon Cho
Journal:  J Hum Genet       Date:  2016-01-21       Impact factor: 3.172

3.  Further phenotypic features and two novel POC1A variants in a patient with SOFT syndrome: A case report.

Authors:  Songting Li; Yan Zhong; Yongjia Yang; Siping He; Wenjuan He
Journal:  Mol Med Rep       Date:  2021-05-06       Impact factor: 2.952

4.  SOFT Syndrome: The First Case in Iran.

Authors:  Neda Mostofizadeh; Mahshid Gheidarloo; Mahin Hashemipour; Elham Hashemi Dehkordi
Journal:  Adv Biomed Res       Date:  2018-09-21

5.  Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps.

Authors:  Veronica Mericq; Isabel Huang-Doran; Dhekra Al-Naqeb; Javiera Basaure; Claudia Castiglioni; Christiaan de Bruin; Yvonne Hendriks; Enrico Bertini; Fowzan S Alkuraya; Monique Losekoot; Khalid Al-Rubeaan; Robert K Semple; Jan M Wit
Journal:  Eur J Endocrinol       Date:  2022-03-23       Impact factor: 6.558

6.  Truncation of POC1A associated with short stature and extreme insulin resistance.

Authors:  Jian-Hua Chen; Maria Segni; Felicity Payne; Isabel Huang-Doran; Alison Sleigh; Claire Adams; David B Savage; Stephen O'Rahilly; Robert K Semple; Inês Barroso
Journal:  J Mol Endocrinol       Date:  2015-10       Impact factor: 5.098

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.